BTK inhibitor 4b   Click here for help

GtoPdb Ligand ID: 10094

Synonyms: compound 4b [PMID: 30216722]
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: This compound is reported as a selective inhbitor of Bruton's tyrosine kinase (BTK) [2]. Compared to existing BTK inhibitors it has a novel aminotriazine scaffold. Inhibitor 4b has been advanced to preclinical studies for evaluation of its anti-inflammatory potential. This is one of the chemical structures claimed in Carna Bioscience's patent WO2015012149A1 [3].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 3
Rotatable bonds 6
Topological polar surface area 136.25
Molecular weight 498.19
XLogP 4.19
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES OCc1c(cccc1n1ccc2c(c1=O)c(F)cc(c2)C1CC1)c1nc(N)nc(n1)Nc1cnn(c1)C
Isomeric SMILES OCc1c(cccc1n1ccc2c(c1=O)c(F)cc(c2)C1CC1)c1nc(N)nc(n1)Nc1cnn(c1)C
InChI InChI=1S/C26H23FN8O2/c1-34-12-17(11-29-34)30-26-32-23(31-25(28)33-26)18-3-2-4-21(19(18)13-36)35-8-7-15-9-16(14-5-6-14)10-20(27)22(15)24(35)37/h2-4,7-12,14,36H,5-6,13H2,1H3,(H3,28,30,31,32,33)
Bioactivity Comments
Inhibitor 4b has an IC50 of 4.2 nM for activated (i.e. phosphorylated) BTK [2]. 300 nM inhibitor 4b inhibits the related Tec family kinases BMX by 80% and TEC by 99.5%. As both of these kinases are also involved in inflammation [1] this selectivity profile might augment BTK inhibition's anti-inflammatory effect. It has limited hERG liability (IC50 24 μM).
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Bruton tyrosine kinase Primary target of this compound Hs Inhibitor Inhibition 9.4 pIC50 - 2
pIC50 9.4 (IC50 3.9x10-10 M) [2]
Description: Inhibition of unactivated (non-phosphorylated) BTK in vitro.